Foreign Firms To Raise Investment In China's OTC Market - IMS
This article was originally published in PharmAsia News
Executive Summary
More and more international companies contributing to large market shares in Europe will raise their investment in expanding their OTC markets in China, predicted Lin Yuechen, head of IMS China Health Market Research Consulting